LDN in PPMS Study
Submitted by Graham(UK) on Thu, 2008-09-11 06:10.
A small study looked at the safety and tolerability of LDN in people with primary progressive MS (PPMS). They found it to be safe and well tolerated. Secondary endpoints found a reduction in spasticity.
It's good to see the controlled studies starting up on this drug. They are long overdue.